MBNL3 Antikörper (AA 116-211) (HRP)
-
- Target Alle MBNL3 Antikörper anzeigen
- MBNL3 (Muscleblind-Like Splicing Regulator 3 (MBNL3))
-
Bindungsspezifität
- AA 116-211
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MBNL3 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Muscleblind-like protein 3 protein (116-211AA)
- Isotyp
- IgG
- Top Product
- Discover our top product MBNL3 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- MBNL3 (Muscleblind-Like Splicing Regulator 3 (MBNL3))
- Andere Bezeichnung
- MBNL3 (MBNL3 Produkte)
- Synonyme
- A530038J18Rik antikoerper, AI661274 antikoerper, CHCR antikoerper, E430034C16Rik antikoerper, MBLX antikoerper, MBLX39 antikoerper, MBXL antikoerper, mbxl antikoerper, RGD1565834 antikoerper, muscleblind like splicing regulator 3 antikoerper, muscleblind like splicing factor 3 antikoerper, Muscleblind-like protein 3-like antikoerper, muscleblind-like splicing regulator 3 antikoerper, MBNL3 antikoerper, Mbnl3 antikoerper, mbnl3 antikoerper
- Hintergrund
-
Background: Mediates pre-mRNA alternative splicing regulation. Acts either as activator or repressor of splicing on specific pre-mRNA targets. Inhibits cardiac troponin-T (TNNT2) pre-mRNA exon inclusion but induces insulin receptor (IR) pre-mRNA exon inclusion in muscle. Antagonizes the alternative splicing activity pattern of CELF proteins. May play a role in myotonic dystrophy pathophysiology (DM). Could inhibit terminal muscle differentiation, acting at approximately the time of myogenin induction.
Aliases: A530038J18Rik antibody, AI661274 antibody, CHCR antibody, Cys3His CCG1 required protein antibody, Cys3His CCG1-required protein antibody, E430034C16Rik antibody, MBLX antibody, MBLX39 antibody, MBNL 3 antibody, Mbnl3 antibody, MBNL3_HUMAN antibody, MBXL antibody, Muscleblind like 3 antibody, Muscleblind like protein 3 antibody, Muscleblind like splicing regulator 3 antibody, Muscleblind like X linked protein antibody, Muscleblind-like protein 3 antibody, Muscleblind-like X-linked protein antibody, OTTMUSP00000019072 antibody, OTTMUSP00000019073 antibody, OTTMUSP00000019074 antibody, Protein HCHCR antibody, RP23-98P13.1 antibody
- UniProt
- Q9NUK0
- Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
-